Om

20/20 Biolabs, Inc. is a commercial-stage diagnostics company focused on AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. The company’s core offerings include the OneTest family, which covers multi-cancer early detection testing and longevity-related biomarker analysis. It also operates CLIAx, a clinical laboratory innovation platform that supports diagnostic development and testing workflows for emerging health technology companies. 20/20 Biolabs serves the healthcare diagnostics market with products and services designed to improve clinical utility through machine learning and real-world data. Based in Gaithersburg, Maryland, the company plays a role in expanding access to advanced laboratory testing and supporting broader adoption of precision diagnostics.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I 20/20 BIOLABS MED ENDAVU: Køb 20/20 Biolabs ($AIDX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i 20/20 Biolabs, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.